Key data on minimally invasive techniques for cardiovascular disease teams

Contrary to earlier assumptions, real-world registries complement randomized trial evidence, as discussed in the accompanying commentary. Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, and this trend is expected to continue. Across multiple cohorts, training and accreditation are decisive for reproducibility, particularly in resource-constrained settings. Contrary to earlier assumptions, cost considerations continue to shape adoption in smaller units, a finding echoed by several independent groups.

Contrary to earlier assumptions, real-world registries complement randomized trial evidence, with meaningful differences between subgroups. Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, pending validation in prospective studies. In multidisciplinary settings, digital tooling shortens time-to-decision considerably, as discussed in the accompanying commentary. When protocols are compared, patient selection criteria deserve closer scrutiny, with meaningful differences between subgroups. Across multiple cohorts, threshold harmonization is still an open question, as discussed in the accompanying commentary.